|
| 38073528 | Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry. | | 2024 |
| 37739266 | Development of the Generalized Pustular Psoriasis Clinical Assessment Tool. | | 2024 |
| 37739267 | Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry. | | 2024 |
| 31525439 | Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disorders. | Journal of the American Academy of Dermatology | 2023 |
| 36319014 | Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. | Journal of Rheumatology | 2023 |
| 36446939 | Evaluation of Skindex-16 construct validity in routinely collected psoriasis data: a retrospective analysis of the relationship between overall physician global assessment scores and Skindex-16 and measure discordance. | Archives of Dermatological Research | 2023 |
| 37657796 | Advances and Controversies in Our Understanding of Guttate and Plaque Psoriasis. | | 2023 |
| 38079199 | Defining what matters through core outcomes set development: Uniting stakeholder perspectives, empowering patient voices. | | 2023 |
| 36585606 | Real-World Effectiveness of 9-12Â Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry. | | 2023 |
| 37075220 | The Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) score: online assessment and validation study of a specific measure of GPP disease activity. | | 2023 |
| 36484917 | Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score⿿⿥⿿2 in the CorEvitas Psoriasis Registry. | | 2023 |
| 36930429 | The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry. | | 2023 |
| 37527861 | Proceedings of the GRAPPA 2022 Executive Retreat. | J Rheumatol | 2023 |
| 32585276 | Measuring quality in psoriasis: Early experiences with the MIPS 410 quality measure-A cross-sectional study. | Journal of the American Academy of Dermatology | 2023 |
| 34878491 | Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States. | JAMA Dermatol | 2022 |
| 35428713 | Challenges in the Diagnosis and Assessment of Psoriatic Arthritis. | Journal of Rheumatology | 2022 |
| 35428707 | 2021 GRAPPA Meet the Experts Session: A Summary of Presentations. | Journal of Rheumatology | 2022 |
| 33465432 | Assessing psoriasis severity: Psychometric validation of overall physician global assessment. | Journal of the American Academy of Dermatology | 2022 |
| 34343599 | Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial. | Journal of the American Academy of Dermatology | 2022 |
| 35293335 | Promoting Diversity, Equity, and Inclusion for Psoriatic Diseases. | Journal of Rheumatology | 2022 |
| 34727299 | Clinicians' perspectives on the integration of electronic patient-reported outcomes into dermatology clinics: a qualitative study. | Quality of Life Research | 2022 |
| 35169061 | Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). | J Rheumatol | 2022 |
| 34822121 | Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas' Psoriasis Registry. | Dermatology and Therapy | 2022 |
| 34878495 | Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States. | JAMA Dermatol | 2022 |
| 33649070 | Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group. | J Rheumatol | 2021 |
| 31962340 | Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry. | Dermatology | 2021 |
| 31991410 | Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM). | Dermatology | 2021 |
| 33858978 | Psoriasis Characteristics for the Early Detection of Psoriatic Arthritis. | Journal of Rheumatology | 2021 |
| 33589551 | Prologue: 2020 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). | J Rheumatol | 2021 |
| 34074670 | Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group. | J Rheumatol Suppl | 2021 |
| 34074664 | Pustular Psoriasis and Associated Musculoskeletal Disorders. | Journal of rheumatology. Supplement, The | 2021 |
| 34074662 | Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting. | Journal of rheumatology. Supplement, The | 2021 |
| 34074657 | Prologue: 2020 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). | J Rheumatol Suppl | 2021 |
| 33722951 | Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual Meeting. | Journal of Rheumatology | 2021 |
| 33722939 | Pustular Psoriasis and Associated Musculoskeletal Disorders. | Journal of Rheumatology | 2021 |
| 31163240 | Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials. | Journal of the American Academy of Dermatology | 2020 |
| 31950353 | Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative. | | 2020 |
| 32088207 | A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S). | | 2020 |
| 32482768 | The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates. | J Rheumatol Suppl | 2020 |
| 32482765 | Methotrexate in Psoriasis and Psoriatic Arthritis. | Journal of rheumatology. Supplement, The | 2020 |
| 32482764 | Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting. | J Rheumatol Suppl | 2020 |
| 32482760 | Prologue: 2019 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). | J Rheumatol Suppl | 2020 |
| 32845288 | Administrative Burden and Costs of Prior Authorizations in a Dermatology Department. | JAMA Dermatology | 2020 |
| 31154397 | Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). | J Rheumatol Suppl | 2019 |
| 30554154 | PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials. | J Rheumatol | 2019 |
| 30317662 | Systemic corticosteroid use in psoriasis: a national survey of board-certified dermatologists. | Journal of the European Academy of Dermatology and Venereology | 2019 |
| 31228013 | Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council. | | 2019 |
| 31174539 | A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies. | BMC Dermatology | 2019 |
| 31163241 | Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study. | Journal of the American Academy of Dermatology | 2019 |
| 31154402 | The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set. | J Rheumatol Suppl | 2019 |